METHOD OF GENETIC MODIFICATION OF A WILD TYPE VIRAL SEQUENCE

Abstract: The present invention concerns a method of genetic modification of a TGB-3 wild type viral sequence for reducing or suppressing the possible deleterious effects of the agronomic properties of a transformed plant or plant cell by said TGB-3 viral sequence, comprising the following successive steps: submitting said sequence to point mutation(s) which allow the substitution of at least one amino-acid into a different amino-acid; selecting genetically modified TGB-3 wild type viral sequences having said point mutation(s) and which are not able to promote cell-to-cell movement of a mutant virus having a dysfunctional TGB-3 wild type viral sequence, when expressed in trans from a replicon; further selecting among said genetically modified TGB-3 viral sequences, the specifically genetically modified sequence which inhibits infection with a co-inoculated wild type virus when the mutant form was expressed from a replicon; and recovering said specifically genetically modified TGB-3 viral sequence.

Description: METHOD OF GENETIC MODIFICATION OF A WILD TYPE VIRAL SEQUENCE Field of the invention The present invention is related to a method of genetic modification of a wild type viral sequence, for reducing or suppressing deleterious properties of plants or plant cells transformed by said wild type viral sequence. The present invention is also related to the modified viral sequence obtained by said method, and to the plant and the plant cell comprising said modified viral sequence. Background of the invention and state of the art The widespread viral disease of the sugar beet plant (Beta vulaaris) called Rhizomania is caused by a furovirus, the beet necrotic yellow vein virus (BNYW) (1, 2) which is transmitted to the root of the beet by the soilborne fungus Polymyxa betae (3) . The disease affects significantly acreages of the area where the sugar beet plant is grown for industrial use in Europe, USA and Japan and is still in extension in several places in Western Europe (4, 5) . Since 1986, number of reports and publications have described the use of isolated viral nucleotidic sequences expressed in plants to confer a high level of tolerance against a specific infectious virus or even to confer a broad spectrum type of resistance against a number of related viruses (6, 7, 8) . One of the most documented viral resistance strategy based on genetic engineering, in many cultivated species such as potato, squash, cucumber or tomato, is the use of the viral nucleotidic sequence which under the control of plant regulatory elements, encodes the coat -protein of the target virus (9) . However, in coat -protein mediated resistance, the expression of a certain level of resistance in the transgenic plant might be attributed to different mechanisms such as RNA co-suppression and not necessarily to the production of the protein sequence. In general, the virus sequence will be transformed in an appropriate cell or tissue culture of the plant species using an Aaroba cterium mediated transformation system or a direct gene transfer method according to the constraints of the tissue culture or cell culture method which can be successfully applied in a given species. A whole plant will be regenerated and the expression of the transgene will be characterised. Though sugar beet is known as a recalcitrant species in cell culture, limiting the extent of practical genetic engineering applications in that species, there are number of isolated reports of successful transformation and regeneration of whole plants (38) . A few examples of engineering tolerance to the BNYW by transforming and expressing the BNYW coat-protein sequence in the sugar beet genome have also been published (11, W091/13159) though they rarely report data on whole functional transgenic sugar beet plants (12) . In particular, reports show limited data on the level of resistance observed in infected conditions with transgenic sugar beet plants transformed with a gene encoding a BNYW coat -protein sequence (13, 14) . A complete technology package including a sugar beet transformation method and the use of the expression of the BNYW coat-protein sequence as resistance source in the transgenic sugar beet plant obtained by said transformation method has been described in the Patent Application W091/13159. Based on the information published, it can not be concluded that the coat -protein mediated resistance mechanism provides any potential for conferring to the sugar beet plant a total immunity to the BNYW- infection by inhibiting completely the virus multiplication and diffusion mechanisms. To identify a resistance mechanism which significantly blocks the spread of the virus at the early stage of the infection process would be a major criteria of success to develop such a transgenic resistance. In addition, such resistance would diversify the mechanisms of resistance available. Because the disease is shown to expand in many countries or areas, at a speed depending upon the combination of numerous local environmental and agricultural factors, there is a major interest to diversification and improvement of the genetic resistance mechanisms which may, alone or in combination, confer a stable and long lasting resistance strategy in the current and future varieties of sugar beet plants which are grown for industrial use. The genome of beet necrotic yellow vein furovirus (BNYW) consists of five plus-sense RNAs, two of which (RNAs 1 and 2) encode functions essential for infection of all plants while the other three (RNAs 3, 4 and 5) are implicated in vector-mediated infection of sugar beet (Beta vulaaris) roots. Cell-to-cell movement of BNYW is governed by a set of three successive, slightly overlapping viral genes on RNA 2 known as the triple gene block (TGB) , which encode, in order, the viral proteins P42, P13 and P15 (gene products are designated by their calculated M r in kilodalton) . In the following description, the TGB genes and the corresponding proteins will be identified by the following terms : TGB-1, TGB-2, TGB-3 or by their encoded viral protein number P42, P13 and P15. TGB counterparts are present in other furoviruses and in potex- , carla- and hordeiviruses (15, 18, 19, 20, 21 and 22) . In the enclosed table 1 are represented viruses having a TGB-3 sequence, the molecular weight of TGB-3 of said viruses, their host and references. It has been shown previously that independent expression of P15 from a viral -RNA replication species known as a "replicon", derived from BNYW RNA 3, inhibits infection with BNYW by interfering cell-to-cell movement (16) . In order to introduce a virus comprising a TGB-3 nucleic acid sequence into a plant cell or a plant, it has been proposed to incorporate a nucleic acid construct comprising said TGB-3 nucleic acid sequence operably linked to one or more regulatory sequences active in said plant (WO98/07875) . However, while expression of wild type TGB-3 viral sequence in a transgenic plant allows the blocking of said viral infection, the presence of said wild type sequence may induce deleterious effects on the agronomic properties of transformed plants or plant cells. Aims of the invention The present invention aims to provide a new method for inducing a genetic modification of a wild type viral sequence involved in the multiplication and diffusion mechanisms of virus infecting plants, in order to reduce or suppress the possible deleterious effects upon plants or plant cells transformed by said viral sequence. Another aim of the present invention is to provide a method to obtain such a modified viral sequence which blocks virus infection when it is incorporated into a plant or a plant cell. Summary of the invention The present invention is related to a method of genetic modification of a TGB-3 wild type viral sequence, preferably the BNYW P15 viral sequence, for reducing or suppressing the possible deleterious effects on the agronomic properties of the transformed plants or plant cells by said TGB-3 viral sequence. Preferably, said genetic modification is a point mutation which allows the substitution of at least one amino-acid into another different amino-acid of said TGB-3 wild type sequence, preferably the substitution of at least one amino-acid into another different amino-acid in the BNYW P15 sequence. It seems that the function of the TGB-3 wild type sequence in cell-to-cell movement involves at least in part "bridging" interactions between an element of the host plant (preferably a component of the plasmodesmata) , and an element of viral origin (preferably another viral protein involved in cell-to-cell movement) . Disruption of either the domain of the TGB-3 wild type sequence (which putatively interacts with the host element) or the domain of the TGB-3 wild type sequence (which putatively interacts with the viral element) , allows the inhibition of the cell- to-cell movement. In addition, it seems that said specific mutations in a TGB-3 wild type sequence allow the production of mutants produced in a transgenic plant, which will still interact with the viral element, but not with the host element . These mutants might compete for binding sites on the viral element of the TGB-3 wild type sequence produced in the initial stage of the viral infection, and abort the infection by inhibiting viral movement to an adjacent cell. Advantageously, the substitution of at least one amino-acid into another different amino-acid of said sequence is made in regions rich in hydrophilic amino-acids usually present at the surface of the protein in its native configuration . Preferably, the point mutation (s) allow the substitution of one or two amino-acids into one or two different amino-acids. In the enclosed Table 1, preferred examples of said viruses having a TGB-3 wild type viral sequence, the molecular weight of the corresponding TGB-3 peptide, their hosts and a reference, are described. The specific wild type P15 nucleotidic and amino-acid sequences of BNYW are also already described (17) . The above-described point mutations were realised by conventional methods known by the person skilled in the art. The above mutants containing the point mutation were tested for their ability to promote cell-to- cell movement of a viral mutant (with a dysfunctional TGB-3 sequence, preferably a BNYW mutant with a dysfunctional P15 gene) when expressed in trans from a replicon. These mutants were incapable of promoting such movement and were tested for their ability to inhibit infection with a co-inoculated wild type TGB-3 virus, preferably co-inoculated with a wild type BNYW, when the mutant form of the TGB-3 sequence, preferably the P15 gene, was expressed from a replicon. The Inventors have discovered unexpectedly that the genetic modification method according to the invention (preferably a point mutation) could be used to obtain a modified TGB-3 viral sequence (preferably a modified BNYW P15 sequence) , which is able to block virus infection without producing deleterious effects when incorporated in the genome of a plant or a plant cell . It is meant by "being able to block viral infection into a plant or a plant cell", the possibility to obtain a high degree of tolerance by the plant or plant cell transformed by said modified TGB-3 viral sequence to said viral infection, in particular the possibility to ensure rapid and total blocking of the virus multiplication and diffusion mechanisms into the plant, preferably the blocking of the BNYW virus multiplication and diffusion mechanisms into a sugar beet plant (beta vulgaris) , including fodder beet, Swiss Whard and table beet which may also be subjected to said BNYW infection. Said tolerance or resistance could be easily measured by various methods well known by the person skilled in the art. Preferably, the genetic modifications in the TGB-3 wild type viral sequence are point mutations in the portions of said wild type viral sequence involved in the mechanisms of viral cell-to-cell movements. The present invention is also related to the modified TGB-3 viral nucleotidic and amino-acid sequences obtained (recovered) by said (modification and selection) method, more preferably the BNYW P15 modified nucleotidic and amino-acid sequences obtained (recovered) by said method. Preferably, said BNYW P15 nucleotidic and amino-acid sequences are selected from the group consisting of the following nucleotidic or corresponding amino-acid sequences : SEO ID NO 1 : ATGGTGCTTGTGGTTGCAGTAGCTTTATCTAATATTGTATTGTACATAGTTGCCGGTTGT 60 M V L V V A V A L S N I V L Y I V A G C GTTGTTGTCAGTATGTTGTACTCACCGTTTTTCAGCAACGATGTTAAAGCGTCCAGCTAT 120 V V V S M L Y S P F F S N D V K A S S Y GCGGGAGCAATTTTTAAGGGGAGCGGCTGTATCATGGACAGGAATTCGTTTGCTCAATTT 180 A G A I F K G S G C I M D R N S F A Q F GGGAGTTGCGATATTCCAAAGCATGTAGCCGAGTCCATCACTAAGGTTGCCACCAAAGAG 240 G S C D I P K H V A E S I T K V A T K E CACGATGTTGACATAATGGTAAAAAGGGGTGAAGTGACCGTTCGTGTTGTGACTCTCACC 300 H D V D I M V K R G E V T V R V V T L T GAAACTATTTTTATAATATTATCTAGATTGTTTGGTTTGGCGGTGTTTTTGTTCATGATA 360 E T I F I I L S R L F G L A V F L F M I TGTTTAATGTCTATAGTTTGGTTTTGGTATCATAGATAA 399 C L S I V W F W Y H R * SEΩ TD NO 2 : ATGGTGCTTGTGGTTAAAGTAGATTTATCTAATATTGTATTGTACATAGTTGCCGGTTGT 60 V L V V K V D L S N I V L Y I V A G C GTTGTTGTCAGTATGTTGTACTCACCGTTTTTCAGCAACGATGTTAAAGCGTCCAGCTAT 120 V V V S L Y S P F F S N D V K A S S Y GCGGGAGCAATTTTTAAGGGGAGCGGCTGTATCATGGCCGCGAATTCGTTTGCTCAATTT 180 A G A I F K G S G C I M A A N S F A Q F GGGAGTTGCGATATTCCAAAGCATGTAGCCGAGTCCATCACTAAGGTTGCCACCAAAGAG 240 G S C D I P K H V A E S I T K V A T K E CACGATGTTGACATAATGGTAAAAAGGGGTGAAGTGACCGTTCGTGTTGTGACTCTCACC 300 H D V D I M V K R G E V T V R V V T L T GAAACTATTTTTATAATATTATCTAGATTGTTTGGTTTGGCGGTGTTTTTGTTCATGATA 360 E T I F I I L S R L F G L A V F L F M I TGTTTAATGTCTATAGTTTGGTTTTGGTATCATAGATAA 399 C L M S I V W F W Y H R * SEQ ID NO 3 : ATGGTGCTTGTGGTTAAAGTAGATTTATCTAATATTGTATTGTACATAGTTGCCGGTTGT 60 M V L V V K V D L S N I V L Y I V A G C GTTGTTGTCAGTATGTTGTACTCACCGTTTTTCAGCAACGATGTTAAAGCGTCCAGCTAT 120 V V V S M L Y S P F F S N D V K A S S Y GCGGGAGCAATTTTTAAGGGGAGCGGCTGTATCATGGACAGGAATTCGTTTGCTCAATTT 180 A G A I F K G S G C I M D R N S F A Q F GGGAGTTGCGATATTCCAAAGCATGTAGCCGAGTCCATCACTAAGGTTGCCACCAAAGAG 240 G S C D I P K H V A E S I T K V A T K E CACGATGTTGACATAATGGTAAAAAGGGGTGAAGTGACCGTTCGTGTTGTGACTCTCACC 300 H D V D I M V K R G E V T V R V V T L T GAAACTATTTTTATAATATTATCTAGATTGTTTGGTTTGGATGATTTTTTGTTCATGATA 360 E T I F I I L S R L F G L D D F L F M I TGTTTAATGTCTATAGTTTGGTTTTGGTATCATAGATAA 399 C L M S I V W F W Y H R * In the following description, the various modified BNYW TGB-3 sequences will be hereafter called "P15 mutants", identified by the following reference : BNP15-Alal, corresponding to SEQ ID NO 1, BNP15-Ala4 corresponding to SEQ ID NO 2, BNP15-Asp9, corresponding to SEQ ID NO 3. The nucleotidic and corresponding amino-acid sequences of SEQ ID NO 1, SEQ ID NO 2 and SEQ ID NO 3 can be compared to SEQ ID NO 4, which is the sequence of the wild type P15 nucleotidic and amino-acid sequence already described (17) . The present invention is also related to the vector comprising said modified nucleotidic sequence possibly being operably linked to one or more regulatory sequence (s) active into a plant or a plant cell. Preferably, said vector is a plasmid comprising already said regulatory sequence (s) active into a plant or a plant cell. The present invention is also related to a method for inducing a resistance to a virus comprising a TGB-3 sequence, preferably one of the viruses described in the enclosed Table 1, and more preferably the BNYW virus, said method comprising the following steps : - preparing a nucleic acid construct comprising a nucleic acid sequence being genetically modified according to the method of the invention and being operably linked to one or more regulatory sequences active into a plant or a plant cell, - transforming the plant cell with the nucleic acid construct, and - possibly regenerating the transgenic plant from the transformed plant cell. Preferably, said method is used for inducing a resistance to the BNYW into a sugar beet plant or a sugar beet cell. Said method comprises the following steps : - preparing a nucleic acid construct comprising a modified nucleic acid sequence obtained by the method according to the invention, preferably preparing a nucleic acid construct comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2 or SEQ ID NO 3, being operably linked to one or more regulatory sequences active into a plant, - transforming the sugar beet plant cell with the nucleic acid construct, and - possibly regenerating the transgenic sugar beet plant from the transformed sugar beet plant cell. The present invention is also related to the obtained (recovered) transgenic plant or the transgenic plant cell resistant to an infection by a virus comprising a TGB-3 sequence, preferably one of the viruses described in the enclosed Table 1, more preferably the BNYW virus, said plant or plant cell comprising a nucleic acid construct having a TGB-3 modified nucleic acid sequence, being operably linked to one or more regulatory sequences capable of being active into a plant or a plant cell. Preferably, said modified nucleic acid sequence is selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2 and SEQ ID NO 3, being operably linked to one or more regulatory sequences active into a plant or a plant cell. Preferably, the cell is a stomatal cell and the regulatory sequence comprises a promoter sequence and a terminator sequence capable of being active into a plant. Said promoter sequence can be constitutive or could be obtained from a foreigner promoter sequence, and is preferably selected from the group consisting of the 35S Cauliflower Mosaic Virus promoter, and/or the polyubiquitin Arabidopsis thaliana promoter. Advantageously, the promoter sequence is a promoter which is mainly capable of being active in the root tissue of plants such , as the par promoter or the haemoglobin gene from Perosponia andersonii. A last aspect of the present invention is related to a transgenic plant tissue such as fruit, stem, root, tuber, seed of the transgenic plant according to the invention or a reproducible structure (preferably selected from the group consisting of calluses, buds or embryos) obtained from the transgenic plant or the plant cell according to the invention. The techniques of plant transformation, tissue culture and regeneration used in the method according to the invention are the ones well known by the person skilled in the art. Such techniques are preferably the ones described in the International Patent Applications WO95/101778, W091/13159 (corresponding to the European Patent Application EP-B-0517833 ) , WO98/07875, which are incorporated herein by reference. These techniques are preferably used for the preparation of transgenic sugar beet plants and plant cells according to the invention. REFERENCES 1. Tamada T. & Baba T., Annals of the Phytopathologi cal Society of Japan 39, pp. 325-332 (1973) 2. Kuszala M.& Putz C., Annals of Phytopathology 9 , pp. 435-446 (1977) 3. Keskin B., Archiv fur Mikrobiology 49, pp. 348-374 (1964) 4. Asher M.J.C., Rhizomania In The sugar beet crop, ed. D.A. Cooke and R.K. Scott, Chapman & Hall, London, pp. 312-338 (1993) 5. Richard-Molard M. , Rhizomanie In Znstitut franςais de la betterave industriell e . Co pte-rendu des travaux effectues en 1994, ITB, Paris pp. 225-229 (1995) 6. Powell A. P. et al . , Science 232, pp. 738-743 (1986) 7. Fritchen J.H. & Beachy R.N. , Ann. .Rev. Microbiol . 47, pp. 739-763 (1993) 8. Wilson T.M.A., Proc . Natl . Acad . Sci . USA 90, pp. 3134- 3141 (1993) 9. Gonsalves D. & Slightom J.L., Seminars in Virology 4, pp. 397-405 (1993) 10. D'Halluin K. et al . , Biotechnology 10, pp. 309-314 (1992) 11. Kallerhof J. et al . , Plant Cell Reports 9, pp. 224-228 (1990) 12. Ehlers U. et al . , Theoretical and Applied Genetic 81, pp. 777-782 (1991) 13. Kraus J. et al . , Fi eld performance of transgenic sugar beet plants expresing BNYW coat protein plants, Fourth International Congress of Plant Mol ecular Biology, Int . Soc . for Plant Molecular Biology, Amsterdam (1994) 14. Maiss E. et al . , Proceedings of the Third International Symposium on the Biosafety Resul ts of Fi eld Tes ts of Genetically Modified Plants and Microorganisms, Monterey, pp. 129-139 (1994) 15. Gilmer et al . , Virology 189, pp. 40-47 (1992) 16. Bleykasten-Grosshans et al . , Mol. Plant-Microbe Interact. 10, pp. 240-246 (1997) 17. Bouzoubaa et al . , J " . Gen. Virol. 67, pp. 1689-1700 (1986) 18. Richards & Tamada, Arxnu. Revendication. Phytopathol. 30, pp. 291-313 (1992) 19. Bouzoubaa et al . , J. Gen. Virol. 68, pp. 615-626 (1987) 20. Herzog et al . , J. Gen. Virol. 18, pp. 3147-3155 (1994) 21. Scott et al., J " . Gen. Virol. 75, pp. 3561-3568 (1994) 22. Koonin & Dolja, Crit. Revendication. Biochem. and Mol. Biol. 28, pp. 375-430 (1993) Table 1 SEQUENCE LISTING <110> SES EUROPE N.V./S.A. <120> METHOD OF GENETIC MODIFICATION OF A WILD TYPE VIRAL SEQUENCE <130> P.SES.02/WO <140> <141> <160> 6 <170> Patentln Ver. 2.1 <210> 1 <211> 399 <212> DNA <213> Artificial Sequence <220> <221> CDS <222> (1) .. (399) <220> <223> Description of Artificial Sequence: genetically modified TGB-3 viral sequence <400> 1 atg gtg ctt gtg gtt gca gta get tta tct aat att gta ttg tac ata 48 Met Val Leu Val Val Ala Val Ala Leu Ser Asn lie Val Leu Tyr lie 1 5 10 15 gtt gcc ggt tgt gtt gtt gtc agt atg ttg tac tea ccg ttt ttc age 96 Val Ala Gly Cys Val Val Val Ser Met Leu Tyr Ser Pro Phe Phe Ser 20 25 30 aac gat gtt aaa gcg tec age tat gcg gga gca att ttt aag ggg age 144 Asn Asp Val Lys Ala Ser Ser Tyr Ala Gly Ala lie Phe Lys Gly Ser 35 40 45 ggc tgt ate atg gac agg aat teg ttt get caa ttt ggg agt tgc gat 192 Gly Cys lie Met Asp Arg Asn Ser Phe Ala Gin Phe Gly Ser Cys Asp 50 55 60 att cca aag cat gta gcc gag tec ate act aag gtt gcc ace aaa gag 240 lie Pro Lys H s Val Ala Glu Ser lie Thr Lys Val Ala Thr Lys Glu 65 70 75 80 cac gat gtt gac ata atg gta aaa agg ggt gaa gtg ace gtt cgt gtt 288 His Asp Val Asp lie Met Val Lys Arg Gly Glu Val Thr Val Arg Val 85 90 95 gtg act etc ace gaa act att ttt ata ata tta tct aga ttg ttt ggt 336 Val Thr Leu Thr Glu Thr lie Phe lie lie Leu Ser Arg Leu Phe Gly 100 105 110 ttg gcg gtg ttt ttg ttc atg ata tgt tta atg tct ata gtt tgg ttt 384 Leu Ala Val Phe Leu Phe Met lie Cys Leu Met Ser lie Val Trp Phe 115 120 125 tgg tat cat aga taa 399 Trp Tyr His Arg 130 <210> 2 <211> 132 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: genetically modified TGB-3 viral sequence <400> 2 Met Val Leu Val Val Ala Val Ala Leu Ser Asn He Val Leu Tyr He 1 5 10 15 Val Ala Gly Cys Val Val Val Ser Met Leu Tyr Ser Pro Phe Phe Ser 20 25 30 Asn Asp Val Lys Ala Ser Ser Tyr Ala Gly Ala He Phe Lys Gly Ser 35 40 45 Gly Cys He Met Asp Arg Asn Ser Phe Ala Gin Phe Gly Ser Cys Asp 50 55 60 He Pro Lys His Val Ala Glu Ser He Thr Lys Val Ala Thr Lys Glu 65 70 75 80 His Asp Val Asp He Met Val Lys Arg Gly Glu Val Thr Val Arg Val 85 90 95 Val Thr Leu Thr Glu Thr He Phe He He Leu Ser Arg Leu Phe Gly 100 105 110 Leu Ala Val Phe Leu Phe Met He Cys Leu Met Ser He Val Trp Phe 115 120 125 Trp Tyr His Arg 130 <210> 3 <211> 399 <212> DNA <213> Artificial Sequence <220> <221> CDS <222> (1) .. (399) <220> <223> Description of Artificial Sequence: genetically modified TGB-3 viral sequence <400> 3 atg gtg ctt gtg gtt aaa gta gat tta tct aat att gta ttg tac ata 48 Met Val Leu Val Val Lys Val Asp Leu Ser Asn He Val Leu Tyr He 1 5 10 15 gtt gcc ggt tgt gtt gtt gtc agt atg ttg tac tea ccg ttt ttc age 96 Val Ala Gly Cys Val Val Val Ser Met Leu Tyr Ser Pro Phe Phe Ser 20 25 30 aac gat gtt aaa gcg tec age tat gcg gga gca att ttt aag ggg age 144 Asn Asp Val Lys Ala Ser Ser Tyr Ala Gly Ala He Phe Lys Gly Ser 35 40 45 ggc tgt ate atg gcc gcg aat teg ttt get caa ttt ggg agt tgc gat 192 Gly Cys He Met Ala Ala Asn Ser Phe Ala Gin Phe Gly Ser Cys Asp 50 55 60 att cca aag cat gta gcc gag tec ate act aag gtt gcc ace aaa gag 240 He Pro Lys His Val Ala Glu Ser He Thr Lys Val Ala Thr Lys Glu 65 70 75 80 cac gat gtt gac ata atg gta aaa agg ggt gaa gtg ace gtt cgt gtt 288 His Asp Val Asp He Met Val Lys Arg Gly Glu Val Thr Val Arg Val 85 90 95 gtg act etc ace gaa act att ttt ata ata tta tct aga ttg ttt ggt 336 Val Thr Leu Thr Glu Thr He Phe He life Leu Ser Arg Leu Phe Gly 100 105 110 ttg gcg gtg ttt ttg ttc atg ata tgt tta atg tct ata gtt tgg ttt 384 Leu Ala Val Phe Leu Phe Met He Cys Leu Met Ser He Val Trp Phe 115 120 125 tgg tat cat aga taa 399 Trp Tyr His Arg 130 <210> 4 <211> 132 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: genetically modified TGB-3 viral sequence <400> 4 Met Val Leu Val Val Lys Val Asp Leu Ser Asn He Val Leu Tyr He 1 5 10 15 Val Ala Gly Cys Val Val Val Ser Met Leu Tyr Ser Pro Phe Phe Ser 20 25 30 Asn Asp Val Lys Ala Ser Ser Tyr Ala Gly Ala He Phe Lys Gly Ser 35 40 45 Gly Cys He Met Ala Ala Asn Ser Phe Ala Gin Phe Gly Ser Cys Asp 50 55 60 He Pro Lys His Val Ala Glu Ser He Thr Lys Val Ala Thr Lys Glu 65 70 75 80 His Asp Val Asp He Met Val Lys Arg Gly Glu Val Thr Val Arg Val 85 90 95 Val Thr Leu Thr Glu Thr He Phe He He Leu Ser Arg Leu Phe Gly 100 105 110 Leu Ala Val Phe Leu Phe Met He Cys Leu Met Ser He Val Trp Phe 115 120 125 Trp Tyr His Arg 130 <211> 399 <212> DNA <213> Artificial Sequence <220> <221> CDS <222> (1) .. (399) <220> <223> Description of Artificial Sequence: genetically modified TGB-3 viral sequence <400> 5 atg gtg ctt gtg gtt aaa gta gat tta tct aat att gta ttg tac ata 48 Met Val Leu Val Val Lys Val Asp Leu Ser Asn He Val Leu Tyr He 1 5 10 15 gtt gcc ggt tgt gtt gtt gtc agt atg ttg tac tea ccg ttt ttc age 96 Val Ala Gly Cys Val Val Val Ser Met Leu Tyr Ser Pro Phe Phe Ser 20 25 30 aac gat gtt aaa gcg tec age tat gcg gga gca att ttt aag ggg age 144 Asn Asp Val Lys Ala Ser Ser Tyr Ala Gly Ala He Phe Lys Gly Ser 35 40 45 ggc tgt ate atg gac agg aat teg ttt get caa ttt ggg agt tgc gat 192 Gly Cys He Met Asp Arg Asn Ser Phe Ala Gin Phe Gly Ser Cys Asp 50 55 60 att cca aag cat gta gcc gag tec ate act aag gtt gcc ace aaa gag 240 He Pro Lys His Val Ala Glu Ser He Thr Lys Val Ala Thr Lys Glu 65 70 75 80 cac gat gtt gac ata atg gta aaa agg ggt gaa gtg ace gtt cgt gtt 288 His Asp Val Asp He Met Val Lys Arg Gly Glu Val Thr Val Arg Val 85 90 95 gtg act etc ace gaa act att ttt ata ata tta tct aga ttg ttt ggt 336 Val Thr Leu Thr Glu Thr He Phe He He Leu Ser Arg Leu Phe Gly 100 105 110 ttg gat gat ttt ttg ttc atg ata tgt tta atg tct ata gtt tgg ttt 384 Leu Asp Asp Phe Leu Phe Met He Cys Leu Met Ser He Val Trp Phe 115 120 125 tgg tat cat aga taa 399 Trp Tyr His Arg 130 <210> 6 <211> 132 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: genetically modified TGB-3 viral sequence <400> 6 Met Val Leu Val Val Lys Val Asp Leu Ser Asn He Val Leu Tyr He 1 5 10 15 Val Ala Gly Cys Val Val Val Ser Met Leu Tyr Ser Pro Phe Phe Ser 20 25 30 Asn Asp Val Lys Ala Ser Ser Tyr Ala Gly Ala He Phe Lys Gly Ser 35 40 45 Gly Cys He Met Asp Arg Asn Ser Phe Ala Gin Phe Gly Ser Cys Asp 50 55 60 He Pro Lys His Val Ala Glu Ser He Thr Lys Val Ala Thr Lys Glu 65 70 75 80 His Asp Val Asp He Met Val Lys Arg Gly Glu Val Thr Val Arg Val 85 90 95 Val Thr Leu Thr Glu Thr He Phe He He Leu Ser Arg Leu Phe Gly 100 105 110 Leu Asp Asp Phe Leu Phe Met He Cys Leu Met Ser He Val Trp Phe 115 120 125 Trp Tyr His Arg 130

Claims: CLAIMS 1. Method of genetic modification of a TGB-3 wild type viral sequence for reducing or suppressing the possible deleterious effects of the agronomic properties of a transformed plant or plant cell by said TGB-3 viral sequence, comprising the following successive steps : - submitting said sequence to point mutation (s) which allow the substitution of at least one ammo-acid into a different ammo-acid, - selecting genetically modified TGB-3 wild type viral sequences having said point mutation (s) and which are not able to promote cell-to-cell movement of a mutant virus having a dysfunctional TGB-3 wild type viral sequence, when expressed in trans from a replicon, - further selecting among said genetically modified TGB-3 viral sequences, the specifically genetically modified sequence which inhibits infection with a co- oculated wild type virus when the mutant form was expressed from a replicon, and - recovering said specifically genetically modified TGB-3 viral sequence. 2. Method according to claim 1, wherem the TGB-3 wild type viral sequence is the BNYW P15 sequence. 3. Genetically modified TGB-3 viral sequence obtained by the method according to claim 1 or 2. 4. Genetically modified TGB-3 viral sequence according to claim 3, being selected from the group consisting of the following sequences : SEQ ID NO 1 : ATGGTGCTTGTGGTTGCAGTAGCTTTATCTAATATTGTATTGTACATAGTTGCCGGTTGT 60 M V L V V A V A L S N I V L Y I V A G C GTTGTTGTCAGTATGTTGTACTCACCGTTTTTCAGCAACGATGTTAAAGCGTCCAGCTAT 120 V V V S M L Y S P F F S N D V K A S S Y GCGGGAGCAATTTTTAAGGGGAGCGGCTGTATCATGGACAGGAATTCGTTTGCTCAATTT 180 A G A I F K G S G C I M D R N S F A Q F GGGAGTTGCGATATTCCAAAGCATGTAGCCGAGTCCATCACTAAGGTTGCCACCAAAGAG 240 G S C D I P K H V A E S I T K V A T K E CACGATGTTGACATAATGGTAAAAAGGGGTGAAGTGACCGTTCGTGTTGTGACTCTCACC 300 H D V D I M V K R G E V T V R V V T L T GAAACTATTTTTATAATATTATCTAGATTGTTTGGTTTGGCGGTGTTTTTGTTCATGATA 360 E T I F I I L S R L F G L A V F L F M I TGTTTAATGTCTATAGTTTGGTTTTGGTATCATAGATAA 399 C L M S I V W F W Y H R * SEQ ID NO 2 : ATGGTGCTTGTGGTTAAAGTAGATTTATCTAATATTGTATTGTACATAGTTGCCGGTTGT 60 M V L V V K V D L S N I V L Y I V A G C GTTGTTGTCAGTATGTTGTACTCACCGTTTTTCAGCAACGATGTTAAAGCGTCCAGCTAT 120 V V V S M L Y S P F F S N D V K A S S Y GCGGGAGCAATTTTTAAGGGGAGCGGCTGTATCATGGCCGCGAATTCGTTTGCTCAATTT 180 A G A I F K G S G C I M A . A N S F A Q F GGGAGTTGCGATATTCCAAAGCATGTAGCCGAGTCCATCACTAAGGTTGCCACCAAAGAG 240 G S C D I P K H V A E S I T K V A T K E CACGATGTTGACATAATGGTAAAAAGGGGTGAAGTGACCGTTCGTGTTGTGACTCTCACC 300 H D V D I M V K R G E V T V R V V T L T GAAACTATTTTTATAATATTATCTAGATTGTTTGGTTTGGCGGTGTTTTTGTTCATGATA 360 E T I F I I L S R L F G L A V F L F M I TGTTTAATGTCTATAGTTTGGTTTTGGTATCATAGATAA 399 C L M S I V W F W Y H R * SEQ TO NO 3 : ATGGTGCTTGTGGTTAAAGTAGATTTATCTAATATTGTATTGTACATAGTTGCCGGTTGT 60 M V L V V K V D L S N I V L Y I V A G C GTTGTTGTCAGTATGTTGTACTCACCGTTTTTCAGCAACGATGTTAAAGCGTCCAGCTAT 120 V V V S M L Y S P F F S N D V K A S S Y GCGGGAGCAATTTTTAAGGGGAGCGGCTGTATCATGGACAGGAATTCGTTTGCTCAATTT 180 A G A I F K G S G C I M D R N S F A Q F GGGAGTTGCGATATTCCAAAGCATGTAGCCGAGTCCATCACTAAGGTTGCCACCAAAGAG 240 G S C D I P K H V A E S I T K V A T K E CACGATGTTGACATAATGGTAAAAAGGGGTGAAGTGACCGTTCGTGTTGTGACTCTCACC 300 H D V D I M V K R G E V T V R V V T L T GAAACTATTTTTATAATATTATCTAGATTGTTTGGTTTGGATGAITTTTTGTTCATGATA 360 E T I F I I L S R L F G L D D F L F M I TGTTTAATGTCTATAGTTTGGTTTTGGTATCATAGATAA 399 C L M S I V W F W Y H R * 5. Vector comprising the genetically modified TGB-3 viral sequence according to the claim 3 or 4, possibly linked to one or more regulatory sequence (s) capable of being active into a plant or a plant cell . 6. Method for inducing resistance into a plant or a plant cell to a virus comprising a TGB-3 sequence, comprising the following steps : - preparing a nucleic acid construct comprising a genetically modified TGB-3 viral sequence according to claim 4 or 5 , being operably linked to one or more regulatory sequence (s) capable of being active into a plant or a plant cell, - transforming a plant cell with said nucleic acid construct, and possibly - regenerating a transgenic plant from the transformed plant cell. 7. Method according to claim 6, characterised in that the virus is selected from the group consisting of the apple stem pitting virus, the blueberry scorch virus, the potato virus M, the white clover mosaic virus, the Cymbidium mosaic virus, the barley stripe mosaic virus, the potato mop top virus, the peanut clump virus, the beet soil-borne virus or the BNYW virus. 8. Method according to claim 6 or 7, characterised in that the plant cell is a stomatal cell. 9. Method according to any one of the claims 6 to 8, characterised in that the plant is selected from the group consisting of apple, blueberry, potato, clover, orchid, barley, peanut or sugar beet. 10. Method according to any one of the claims 6 to 9, characterised in that the regulatory sequence comprises a promoter sequence or a terminator sequence active in a plant. 11. Method according to claim 10, characterised in that the promoter sequence is a constitutive or a foreigner promoter sequence. 12. Method according to claim 10, characterised in that the promoter sequence is selected from the group consisting of 35S Cauliflower Mosaic Virus promoter, and/or the polyubiquitin Arabidopsis thaliana promoter. 13. Method according to any one of the claims 10 to 12, characterised in that the promoter sequence is a promoter which is capable of being active mainly into the root tissue of plants such as the par promoter of the haemoglobin gene from Perosponia andersonii . 14. Transgenic plant or transgenic plant cell resistant to a virus and comprising a nucleic acid construct having a genetically modified TGB-3 viral sequence according to claim 4 or 5 , being operably linked to one or more regulatory sequence (s) active into a plant or a plant cell . 15. Transgenic plant or transgenic plant cell according to claim 14, characterised in that the virus is selected from the group consisting of the apple stem pitting virus, the blueberry scorch virus, the potato virus M, the white clover mosaic virus, the Cymbidium mosaic virus, the potato virus X, the barley stripe mosaic virus, the potato mop top virus, the peanut clump virus, the beet soil -borne virus and the BNYW virus. 16. Transgenic plant or transgenic plant cell according to claim 14 or 15, being a plant or a plant cell selected from the group consisting of apple, blueberry, potato, clover, orchid, barley, peanut or sugar beet plant or plant cell . 17. Transgenic plant or transgenic plant cell according to any one of the claims 14 to 16, characterised in that the regulatory sequence comprises a promoter sequence and a terminator sequence capable of being active into a plant. 18. Transgenic plant or transgenic plant cell according to any one of the claims 14 to 17, characterised in that the regulatory sequence (s) comprise a promoter sequence which is a constitutive or a foreigner vegetal promoter sequence. 19. Transgenic plant or transgenic plant cell according to claim 18, characterised in that promoter sequence is selected from the group consisting of 35S Cauliflower Mosaic Virus promoter, and/or the polyubiquitin Arabidopsis thaliana promoter. 20. Transgenic plant or transgenic plant cell according to claim 18 or 19, characterised in that the promoter sequence is a promoter which is mainly active in root tissues such as the par promoter of the haemoglobin gene from Perosponia andersonii. 21. Transgenic plant tissue selected from the group consisting of fruit, stem, root, tuber, seed of a plant according to any one of the claims 14 to 20. 22. Reproducible structure obtained from a transgenic plant according to any one of the claims 14 to 21.

Inventors: GUILLEY HUBERT, JONARD GERARD, LAUBER E, RICHARDS KEN, GUILLEY, HUBERT, JONARD, GERARD, LAUBER, E., RICHARDS, KEN
Applicants: GUILLEY HUBERT, JONARD GERARD, LAUBER E, RICHARDS KEN, SES EUROP N V S A, GUILLEY, HUBERT, JONARD, GERARD, LAUBER, E., RICHARDS, KEN, SES EUROPE N.V./S.A.
Application year: 1999
Main classification: C12N15
IPC codes: A01H5, C07K14, C12N5, C12N15, C12Q1